Objectives: The peroxisome proliferator-activated receptor-alpha (PPAR-α) has attracted considerable attention for its anti-inflammatory properties; however, Toll-like receptor (TLR) pathways have an essential pro-inflammatory role in acute pancreatitis (AP). This study aimed to evaluate the attenuation of inflammation by PPAR-α and to investigate the interaction between PPAR-α and TLR pathways in AP.
Introduction
Acute pancreatitis (AP) is a common but potentially lethal disease that has an increasing incidence. Essentially, AP is an inflammatory disease, the progress and prognosis of which are determined by local and systemic inflammatory responses. Therefore, exploring the intrinsic anti-inflammatory mechanisms is important for controlling the development of pancreatitis.
Peroxisome proliferator-activated receptors (PPARs) are ligand-inducible transcription factors that are members of the class II nuclear hormone receptor superfamily that regulate cellular energy and lipid metabolism. Three subtypes have been identified: PPAR-α, -γ, and-β/δ. Recently, PPARs have attracted wide attention as essential negative regulators in inflammatory responses 1 . PPAR-γ is the most frequently studied protective molecule in several inflammatory responses, such as ischemia/reperfusion, shock and AP 2 . PPAR-α as a general modulator of the inflammatory response was first reported by Devchand et al 3 , who observed that inflammation is prolonged in PPAR-α-deficient mice. Subsequently, it was demonstrated that PPAR-α-deficient mice have abnormally prolonged responses in inflammatory bowel disease 4 . Recent studies have clearly demonstrated that PPAR-α activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier 5 . In AP, PPAR-α-deficient mice show increased pancreatic inflammation and tissue injury 6 . In contrast, it was reported that PPAR-α negatively regulates the vascular inflammatory gene response by negative 'cross-talk' with the transcription factors, NF-κB and AP-1 7 . Based on these results, it was hypothesized that the inflammatory progression in AP can be controlled by modulation of the activity of Ding et al. [4] PPAR-α. This study was designed to investigate the effects of administration of a PPAR-α agonist or/and antagonist on regulation of the pancreatic inflammatory response in caerulein-induced AP in rats.
Toll-like receptors (TLRs) are a group of pattern recognition receptors upstream of NF-κB and AP-1. These molecules, including TLR2, TLR4 and TLR9, have a critical role in the pathogenesis of AP [8] [9] [10] . Ligand binding by TLRs results in activation of a cascade of kinases, leading to nuclear translocation of NF-κB and AP-1, followed by release of cytokines, chemokines and adhesion molecules 11 . Little is known about the possible interaction between the pro-inflammatory TLR pathways and the anti-inflammatory PPAR-α pathway in AP. This study aimed to evaluate attenuation of inflammation by activation of PPAR-α in AP and furthermore, to investigate the role of the TLR signaling pathways in this attenuation.
Materials and Methods

Animals
Male Wistar rats (200-250 g) were used in this study (Experimental Animal Center of Sichuan University, Chengdu, China). All animals were bred and housed in standard shoebox cages in a climate-controlled room with an ambient temperature of 23 ± 2°C and a 12:12-h light-dark cycle. Animals were fed standard laboratory chow and given water ad libitum except for the 12 hours prior to experimentation during which animals were starved and allowed free access to water alone. All animal experiments were conducted according to the guidelines of the local Animal Use and Care Committees and according to the National Animal Welfare Law.
Ding et al.
[5] 
Model preparation and experimental animal grouping
Histological examination
For routine histology, 5-μm sections of 10% formalin-fixed, paraffin-embedded tissue were prepared and stained with hematoxylin and eosin (H&E). All microscopic sections were examined by two independent pathologists who were blinded to the experimental protocol. Pancreatitis severity was scored as previously described 12 . Briefly, necrosis was scored on a 0-3 scale, with 0, normal; 1, periductal necrosis (<5%); 2, focal necrosis (5-20%); 3, diffuse necrosis (>50%). Inflammatory cell infiltration was scored on a 0-3 scale, as follows: 0, normal; 1, inflammatory infiltration in duct; 2, infiltration in the parenchyma (<50%); 3, infiltration in the parenchyma (>50%). Edema was also scored on a 0-3 scale, with 0, normal; 1, focal increase between lobules; 2, diffuse increase between lobules; 3, acini disrupted and separated. The total severity score was the sum of all three scores.
Myeloperoxidase (MPO) measurement
Neutrophil infiltration in the pancreas was quantified by measuring tissue MPO activity using a chromatometric kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China)
according to the instructions provided by the manufacturer. Briefly, after weighing, a segment of pancreatic tissue was suspended in 0.5% hexadecyltrimethylammonium bromide (pH 6.5, 50 mg of tissue per ml) and was then homogenized. After freezing and thawing the homogenate three times, the tissue levels of MPO were detected by using Ding et al. [7] 0.0005% hydrogen peroxide as a substrate for the enzyme. One unit of MPO activity is defined as that degrading 1 μmol of peroxide per minute at 25 o C and is expressed in units per gram weight (U/g) of wet tissue.
Enzyme-linked immunosorbent assay
Rat serum cytokines including interleukin-6 (IL-6) and soluble intercellular adhesion molecule-1(sICAM-1) were determined using enzyme-linked immunosorbent assay (ELISA) kits (R&D, Minneapolis, MN) and performed following the instructions provided by the manufacturer. The result was read by a microplate reader (Bio-Rad, M550, Hercules, CA). IL-6 and sICAM-1 concentrations are expressed in terms of pg/ml and ng/ml, respectively.
Quantitative real-time reverse transcription polymerase chain reaction (RT-PCR)
Fresh pancreatic tissue (50-80 mg/mouse) was collected and total RNA was extracted with TRIzol according to the instructions provided by the manufacturer. Integrity was confirmed by agarose gel electrophoresis. Concentration and purity were determined by ultraviolet spectrophotometry, and the total RNA concentration was calculated. Reverse transcription was performed in 20 µl with 5 μg of total RNA and random hexamers (TaKaRa Biotechnology Co., Ltd, Dalian, China). PCR amplification was performed on 1μl of the resulting cDNA. Specific primers were designed and synthesized by Invitrogen (Invitrogen Biotechnology Co., Ltd, Shanghai, China). The sequences of primers are shown in Table1. All the samples were normalized to β-actin gene. Conditions for all
PCRs were optimized using an iCycler iQ (Bio-Rad, Hercules, CA) in a 25 μl reaction Ding et al. [8] system for 40 cycles. Each cycle consisted of denaturation for 20 s at 94ºC, annealing for 30 s at 55ºC (TLR2, TLR4, and TLR9) or 52ºC (ICAM-1, IL-6, IL-10 and TNF-α) and extension for 30 s at 72ºC. A no-template, ddH 2 O control was included for each template.
All samples were amplified simultaneously in triplicate in a single run. Relative quantitative gene expression was calculated as previously described 13 and expressed as a percentage of the control level.
Western-blotting
For total protein extracts, pancreas samples were homogenized with lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton-X 100, 1% sodium deoxycholate, 1 mM PMSF), and centrifuged at 15,000×g for 10 min at 4ºC. The supernatant was retained for the subsequent protein assays. Protein concentration was determined with a BCA kit (Pierce Biotechnology, Rockford, IL, USA). Extracts were treated with 2 × SDS-polyacry -lamide loading buffer at 95ºC for 10 min, and was separated by electrophoresis on 10%
Tris-HCl polyacrylamide gels at room temperature. Proteins were transferred to 0.45 um polyvinylidene difluoride membranes (Millipore Corporation, Billerica, MA, USA) for 90 min at 300 mA, 4ºC (Bio-Rad Lab, Hercules, CA, USA). Membranes were blocked with 5% non-fat dry milk in TBS-0.05% Tween 20 (TBST) for 1 h at room temperature, washed three times for 10 min each in TBST, and incubated at 4ºC with gentle shaking overnight with primary antibody rabbit anti-rat TLR2 polyclonal antibody (Abcam, Cambridge, UK) at a 1:500 dilution and mouse anti-rat TLR4 monoclonal antibody (Abcam) at a 1:500, in TBST containing 5% non-fat dry milk. After three 10-min TBST washes, membranes were incubated with peroxidase-conjugated goat anti-rabbit IgG at Ding et al.
[9]
1:5,000 (Bio-Rad) and goat anti-rat IgG at 1:5,000 (Bio-Rad) for 1 h at room temperature.
After washing, membranes were analyzed by enhanced chemiluminescence (Pierce Biotechnology).
Statistical analysis
The data were expressed as the mean ± SE. Differences between three or more groups were evaluated by one-way ANOVA. A Student's t-test was used for comparisons of two groups. A P-value of less than 0.05 (2-tailed) was considered statistically significant. All tests were performed using the statistical package SPSS software 11.5 (SPSS, Chicago, IL).
Results
Serum amylase, lipase and Ca
2+ determination
Levels of serum amylase, lipase and Ca 2+ were determined (Figure 1 Figure 1C ).
Histological assessment of inflammation
Rat pancreatic tissues were sampled from all groups and stained by H&E ( Fig. 2A, A1 -5).
No interstitial edema, cellular swelling, inflammatory cells infiltration and sporadic necrosis were detected in the DMSO plus saline (control) group, ( Fig. 2A, A1 (Fig. 2A, A5 ).
Neutrophil infiltration by MPO assay
Neutrophil infiltration was assessed by the activity of MPO, an enzyme specifically 
TLR2 and TLR4 protein levels by western-blotting
Western-blotting was used to see whether pancreatic TLR2 and TLR4 protein levels 
IL-6, TNF-α, IL-10, and ICAM-1 gene expression
[13]
Pancreatic gene expression of IL-6, TNF-α, IL-10, and ICAM-1 was also examined 
Discussion
Peroxisome proliferator-activated receptor-α (PPAR-α) is one of the three subtypes of the nuclear receptor PPAR family. In rats, PPAR-α is most highly expressed in brown adipose tissue and in the pancreas 14 . Activation of PPAR-α, by either natural ligands, such as polyunsaturated fatty acids and eicosanoids, or synthetic ligands, such as fibrates and WY14643, stimulates target-gene transcription via the formation of heterodimeric transcription factor complexes with the retinoid X receptor 15 . PPAR-α has a wide range of effects on metabolism, cellular proliferation and the immune response 16 . A growing body of evidence suggests that PPAR-α activation induces anti-inflammatory effects in a Ding et al.
[ 14] number of organs. Several studies have indicated that WY14643 inhibits the expression of many pro-inflammatory molecules in organs such as the heart and brain against ischemia/reperfusion injury 17, 18 , although its role in acute pancreatitis (AP) is not fully understood. This study investigated the protective effects of PPAR-α activation by the selective agonist WY14643 on rat pancreatitis injury in the caerulein-induced model of AP. MK886 is a high-affinity and specific blocker for PPAR-α, inhibiting the conformational change or preventing other ligands from accessing the conformational-sensitive site of PPAR-α 19 . In the present study , the potential of MK886
to attenuate these protective effects was also examined.
The results obtained revealed that treatment with WY14643 and/or MK886 had no To further characterize the effects of activation of PPAR-α in AP, changes in Ding et al.
[ 15] inflammatory mediators were also examined. The results showed that administration of WY14643 and/or MK886 had no effect on baseline levels of IL-6 and ICAM-1 while levels markedly increased following caerulein treatment. Pretreatment with WY14643
significantly inhibited the increase in levels of IL-6 and ICAM-1 associated with caerulein treatment although co-administration of WY14643 and MK886 significantly diminished the effects of WY14643. Furthermore, MK886 alone resulted in more profoundly increased levels of serum IL-6 and ICAM-1. These data indicate that PPAR-α activity is centrally involved in mediation of the effects of WY14643 and MK886 on AP and that PPAR-α activation attenuates the severity of the inflammatory responses responsible for pancreatic damage in AP. However, the mechanism by which this effect is mediated remains to be elucidated.
Over the past five years, the involvement of Toll-like receptors (TLRs) in the pathophysiology of AP has been recognized 20 . Sharif et al. reported that deletion of TLR4 resulted in significantly less severe AP and associated lung injury assessed by hyperamylasemia, edema, MPO activity and pancreatic necrosis 21 . Therefore, it can be speculated that there is 'cross-talk' between these two counteractive pathways. The results revealed that treatment with WY14643 and/or MK886 had no effect on baseline levels of TLR2, TLR4 and TLR9 mRNA while levels significantly increased following caerulein treatment. The observed increase in TLR2 and TLR4 mRNA expression was markedly downregulated by WY14643 treatment, while this effect was abolished by co-administration of WY14643 (PPAR-α agonist) and MK886 (PPAR-α antagonist).
Furthermore, MK886 alone resulted in profoundly increased expression of TLR2 and TLR4 mRNA. However, in contrast to these effects, TLR9 mRNA expression was not Ding et al.
[ 16] affected by WY14643 and/or MK886. Subsequently, the protein levels of TLR2 and TLR4 were also measured. As expected, the protein levels of TLR2 and TLR4 correlated to changes in their mRNA levels. TLRs are widely expressed in pancreas and are profoundly involved in acute pancreatitis 20 In conclusion, this study clearly demonstrates that activation of PPAR-α Ding et al.
[ 17] significantly reduces pancreatic injury in caerulein-induced pancreatitis. Furthermore, these protective effects are associated with the modulation of TLR signaling pathways, thus indicating the potential of regulation of the PPAR-α pathway as an approach to therapeutic intervention in acute pancreatitis.
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Figure Legends
[22]
B: serum lipase.
[23]
C: serum Ca 2+ .
Results are means ± SE for eight animals per group; * p<0.05 versus DMSO + sal (control) group, # p<0.05 versus DMSO + cae group. sal, saline; cae, caerulein. and/or 30 min before the first caerulein injection. Pancreas was harvested 6h after the first injection of caerulein or saline.
